New molecular and immunotherapeutic approaches in biliary cancer

被引：31

作者：

Goldstein, David ^{[1
,2
]}

Lemech, Charlotte ^{[1
,2
]}

Valle, Juan ^{[3
,4
]}

机构：

[1] Prince Wales Hosp, Nelune Canc Ctr, Dept Med Oncol, Sydney, NSW, Australia

[2] Univ New South Wales, Prince Wales Clin Sch, Sydney, NSW, Australia

[3] Univ Manchester, Inst Canc Studies, Manchester, Lancs, England

[4] Christie NHS Fdn Trust, Manchester, Lancs, England

来源：

ESMO OPEN | 2017年 / 2卷

关键词：

PHASE-II TRIAL; TRACT CANCER; OPEN-LABEL; GALLBLADDER CARCINOMA; PLUS SORAFENIB; GEMCITABINE; COMBINATION; OXALIPLATIN; CETUXIMAB; MULTICENTER;

D O I：

10.1136/esmoopen-2016-000152

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Biliary tract carcinoma is a collective term for a group of rare gastrointestinal cancers. This overview outlines the key pathways and specialised therapeutics in biliary cancer and the emerging role of immunotherapy by highlighting the rationale and selected examples of studies in each area.

引用

页数：9

共 72 条

[21] SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma [J].

El-Khoueiry, Anthony B. ;

Rankin, Cathryn J. ;

Ben-Josef, Edgar ;

Lenz, Heinz-Josef ;

Gold, Philip J. ;

Hamilton, R. Darryl ;

Govindarajan, Rangaswamy ;

Eng, Cathy ;

Blanke, Charles D. .

INVESTIGATIONAL NEW DRUGS, 2012, 30 (04) :1646-1651

[22] Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma [J].

Flaherty, Keith T. ;

Robert, Caroline ;

Hersey, Peter ;

Nathan, Paul ;

Garbe, Claus ;

Milhem, Mohammed ;

Demidov, Lev V. ;

Hassel, Jessica C. ;

Rutkowski, Piotr ;

Mohr, Peter ;

Dummer, Reinhard ;

Trefzer, Uwe ;

Larkin, James M. G. ;

Utikal, Jochen ;

Dreno, Brigitte ;

Nyakas, Marta ;

Middleton, Mark R. ;

Becker, Juergen C. ;

Casey, Michelle ;

Sherman, Laurie J. ;

Wu, Frank S. ;

Ouellet, Daniele ;

Martin, Anne-Marie ;

Patel, Kiran ;

Schadendorf, Dirk .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (02) :107-114

[23]

Fujii T, 2016, DISCOV MED, V21, P373

[24] Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer [J].

Goeppert, B. ;

Frauenschuh, L. ;

Zucknick, M. ;

Stenzinger, A. ;

Andrulis, M. ;

Klauschen, F. ;

Joehrens, K. ;

Warth, A. ;

Renner, M. ;

Mehrabi, A. ;

Hafezi, M. ;

Thelen, A. ;

Schirmacher, P. ;

Weichert, W. .

BRITISH JOURNAL OF CANCER, 2013, 109 (10) :2665-2674

[25] A phase II trial of cabozantinib (XL-184) in patients with advanced cholangiocarcinoma [J].

Goyal, Lipika ;

Yurgelun, Matthew B. ;

Abrams, Thomas Adam ;

Kwak, Eunice Lee ;

Cleary, James M. ;

Knowles, Michelle ;

Regan, Eileen ;

Gisondi, Amy ;

Sheehan, Susan ;

Zheng, Hui ;

Zhu, Andrew X. .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)

[26] Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study [J].

Gruenberger, Birgit ;

Schueller, Johannes ;

Heubrandtner, Ute ;

Wrba, Fritz ;

Tamandl, Dietmar ;

Kaczirek, Klaus ;

Roka, Rudolf ;

Pircher, Sandra Freimann ;

Gruenberger, Thomas .

LANCET ONCOLOGY, 2010, 11 (12) :1142-1148

[27] Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer [J].

Hezel, A. F. ;

Noel, M. S. ;

Allen, J. N. ;

Abrams, T. A. ;

Yurgelun, M. ;

Faris, J. E. ;

Goyal, L. ;

Clark, J. W. ;

Blaszkowsky, L. S. ;

Murphy, J. E. ;

Zheng, H. ;

Khorana, A. A. ;

Connolly, G. C. ;

Hyrien, O. ;

Baran, A. ;

Herr, M. ;

Ng, K. ;

Sheehan, S. ;

Harris, D. J. ;

Regan, E. ;

Borger, D. R. ;

Iafrate, A. J. ;

Fuchs, C. ;

Ryan, D. P. ;

Zhu, A. X. .

BRITISH JOURNAL OF CANCER, 2014, 111 (03) :430-436

[28] Genetics of Biliary Tract Cancers and Emerging Targeted Therapies [J].

Hezel, Aram F. ;

Deshpande, Vikram ;

Zhu, Andrew X. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (21) :3531-3540

[29] A proof-of-concept study of MEK inhibitor trametinib monotherapy in patients with biliary tract cancers [J].

Ioka, T. ;

Ikeda, M. ;

Fukutomi, A. ;

Morizane, C. ;

Kasuga, A. ;

Takada, R. ;

Takahashi, H. ;

Todaka, A. ;

Okusaka, T. ;

Creasy, C. ;

Gorman, S. ;

Felitsky, D. ;

Kawamura, T. ;

Kobayashi, M. ;

Furuse, J. .

EUROPEAN JOURNAL OF CANCER, 2015, 51 :S464-S464

[30]

Iyer RV, 2016, AM J CLIN ONCOL, V1

← 1 2 3 4 5 6 7 8 →